Connexin 26 (GJB2) is one of the major factors in human deafness worldwide. On average 1/1000 children is born deaf and the most common GJB2 variant (c.35delG) causes ∼40% of cases in Southern Europe. Carriers’ frequency for different loss-of-function GJB2 mutations is very high worldwide (up to 3%),1 suggesting a heterozygous advantage for a global condition or a founder effect.2 In this light, epidermal thickening in GJB2 carriers3, 4 has been proposed as a possible advantage reducing infections and bacterial invasion through skin.5, 6 Moreover, in vitro functional studies demonstrated that the loss-of-functional GJB2 expression provides improved protection against gastrointestinal bacterial pathogens.7 In particular, enteropathogenic Escherichia coli and Shigella flexneri may induce a strong selective effect, being the most common causes of diarrhoea. Thus, GJB2 carriers might have an increased resistance to gastrointestinal infectious diseases, as already proposed by Simpson et al.7
To test this hypothesis, a cross-sectional study involving 203 subjects aged 19–65 years (63% women) was carried out. Subjects (170) were wildtype for the GJB2 gene, whereas 33 carried one or more variants. The information about diarrhoea episodes and frequency, medical history and covariates (sex and age) was collected. People self-reporting diarrhoea episodes at least once a year were set as cases, whereas the remaining ones were controls (all the subject had similar level of education) (Table 1; Figure 1). Subjects affected by pertinent chronic diseases (Crohn’s disease, Intestinal bowel disease and so on) were excluded from the study. Fisher’s exact test was performed for case/control proportion in relation to genotype, giving a significant result (P=0.007), with an odds ratio (OR) of 3.21 (95% confidence interval (CI): 1.27–9.24). Although our sample was sex and age homogeneous (Wilcoxon test P>0.05), performing the same analysis separated by sex revealed that females mainly contributed to the finding (P=0.0016). In particular, in our data set women had higher incidence of diarrhoea than men (46% and 36% respectively), and for female GJB2 carriers this proportion dropped to 12.5%, with an OR=8.33 (95% CI: 1.82–78.03). As regards to the reported frequency per die (range: 0–3), linear regression was applied, including covariates, and a significant effect for genotype was detected (P=0.006/0.017 for females/total sample) indicating lower diarrhoea frequency for GJB2 carriers.
In conclusion, present clinical results provide new insights on GJB2 heterozygote advantage, further suggesting that it might consist in an increased resistance to gastrointestinal infections as already demonstrated by in vitro studies. Future research activities should be carried out to further confirm the present finding (eg, increasing the sample size) and to investigate whether GJB2 carriers have a different gut microbiota composition.
Accession codes
References
Estivill X, Fortina P, Surrey S et al: Connexin-26 variants in sporadic and inherited sensorineural deafness. Lancet 1998; 351: 394–398.
Gasparini P, Rabionet R, Barbujani G et al: High carrier frequency of the 35delG deafness variant in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet 2000; 8: 19–23.
Meyer CG, Amedofu GK, Brandner JM, Pohland D, Timmann C, Horstmann RD : Selection for deafness? Nat Med 2002; 8: 1332–1333.
Common JE, Di WL, Davies D, Kelsell DP : Further evidence for heterozygote advantage of GJB2 deafness mutations: a link with cell survival. J Med Genet 2004; 41: 573–575.
D’Adamo P, Guerci VI, Fabretto A et al: Does epidermal thickening explain GJB2 high carrier frequency and heterozygote advantage? Eur J Hum Genet 2009; 17: 284–286.
Man YK, Trolove C, Tattersall D et al: A deafness-associated mutant human connexin 26 improves the epithelial barrier in vitro. J Membr Biol 2007; 218: 29–37.
Simpson C, Kelsell DP, Marchès O : Connexin 26 facilitates gastrointestinal bacterial infection in vitro. Cell Tissue Res 2013; 351: 107–116.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Author contributions
Data collection was done by AF, LM and MDP; study design by DV, PG and BD; data analysis by DV; and writing by DV and PG.
Rights and permissions
About this article
Cite this article
Vuckovic, D., Dallapiccola, B., Franzè, A. et al. Connexin 26 variant carriers have a better gastrointestinal health: is this the heterozygote advantage?. Eur J Hum Genet 23, 563–564 (2015). https://doi.org/10.1038/ejhg.2014.151
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejhg.2014.151
This article is cited by
-
Selective Heterozygous Advantage of Carriers of с.-23+1G>A Mutation in GJB2 Gene Causing Autosomal Recessive Deafness 1A
Bulletin of Experimental Biology and Medicine (2019)